Metformin: A Promising Candidate For Slowing The Progression Of Cardiovascular Aging
Our bodies naturally experience changes as we age, and these changes can impact our cardiovascular system, leading to issues like stiffening arteries and less efficient heart function. Recent research suggests that a common medication, traditionally used to manage blood sugar in people with type 2 diabetes, might also offer a way to slow down these age-related cardiovascular changes. This drug appears to work by influencing several fundamental biological pathways. For instance, it can activate a key enzyme called AMP-activated protein kinase (AMPK), which plays a crucial role in cellular energy balance. It also seems to improve the health of our cells’ powerhouses, the mitochondria, by encouraging the creation of new ones (mitochondrial biogenesis) and reducing harmful oxidative stress, an imbalance that can damage cells. Furthermore, the medication may promote autophagy, a cellular “self-cleaning” process, and help to calm chronic inflammation throughout the body. By modulating these processes, including those that affect our genetic material and biological age markers (epigenetic clocks), this treatment could potentially offer a broader protective effect against the progression of cardiovascular aging.
Source: link to paper